# GHST (GHST World Inc.) - SEC EDGAR Financial Statements

> GHST World Inc. reported $10K in revenue and a net loss of $71K for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -1014.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/GHST
- Markdown: https://convexityos.com/fundamentals/GHST.md
- SEC CIK: 0001121795
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001121795&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $10K | -100.0% YoY |
| Operating Income | TTM | -$105K | -1014.6% margin |
| Net Income | TTM | -$71K | -685.8% net margin |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $766 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $14K | $60K | $41K | $3.1K | -- | -- | -- |
| Research & Development | -- | -- | -- | $4.8K | -- | -- | -- |
| Total Operating Expenses | $135K | $243K | $552K | $119K | $319K | $151K | $38K |
| **Operating Income** | -$121K | -$182K | -$511K | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | $150 | -- | -- |
| Income Before Tax | -$86K | -$183K | -$511K | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- |
| **Net Income** | -$86K | -$183K | -$511K | -$117K | -$3.99M | -$151K | -$151K |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | -$0.07 | -$0.03 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | $0.00 | -$0.07 | -$0.03 | $0.00 |
| Basic Shares Outstanding | 130.2M | 130.2M | 129.1M | 125.0M | 54.0M | 4.8M | 397.9M |
| Diluted Shares Outstanding | 130.2M | 130.2M | 129.1M | 125.0M | 54.0M | 4.8M | 397.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $10K | $3.5K | $5.1K | $4.8K | $4.9K |
| Research & Development | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Total Operating Expenses | $19K | $44K | $26K | $26K | $39K | $97K | $36K | $51K |
| **Operating Income** | -$19K | -$44K | -$26K | -$16K | -$35K | -$92K | -$32K | -$46K |
| Income Before Tax | -$19K | -$10K | -$26K | -$16K | -$34K | -$93K | -$32K | -$46K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -- | $0 | $0 |
| **Net Income** | -$19K | -$10K | -$26K | -$16K | -$34K | -$93K | -$32K | -$46K |
| Basic EPS | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 |
| Basic Shares Outstanding | 130.2M | -- | 130.2M | 130.2M | 130.2M | -- | 130.2M | 130.2M |
| Diluted Shares Outstanding | 130.2M | -- | 130.2M | 130.2M | 130.2M | -- | 130.2M | 130.2M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $861 | $2.5K | $18K | $39K | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $861 | $2.5K | $18K | $39K | $0 | $0 | $0 |
| Accounts Receivable, Net | -- | $0 | $3.7K | $0 | -- | -- | -- |
| **Total Current Assets** | $861 | $2.5K | $22K | $39K | $206 | $7.3K | $292 |
| Other Non-Current Assets | -- | -- | -- | -- | $115K | $115K | $115K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $154K | $147K |
| **Total Assets** | $861 | $2.5K | $22K | $39K | $206 | $162K | $147K |
| Deferred Revenue (Current) | $0 | $38K | $37K | $24K | -- | -- | -- |
| Other Current Liabilities | $550K | $418K | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $578K | $494K | $330K | $161K | $101K | $249K | $256K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $2 | $0 |
| **Total Liabilities** | $578K | $494K | $330K | $161K | $101K | $249K | $256K |
| Common Stock | $130K | $130K | $130K | $126K | $124K | $5.2K | $398K |
| Retained Earnings | -$14.15M | -$14.06M | -$13.88M | -$13.37M | -$13.25M | -$9.27M | -$9.12M |
| **Total Stockholders' Equity** | -$577K | -$491K | -$308K | -$122K | -$101K | -$87K | -$109K |
| Total Equity | -$577K | -$491K | -$308K | -$122K | -$101K | -$87K | -$109K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $766 | $861 | $968 | $1.1K | $1.8K | $2.5K | $144 | $240 |
| **Cash & Short-Term Investments** | $766 | $861 | $968 | $1.1K | $1.8K | $2.5K | $144 | $240 |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $0 | $1.7K | $8.3K |
| **Total Current Assets** | $766 | $861 | $968 | $1.1K | $1.8K | $2.5K | $1.8K | $8.6K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $766 | $861 | $968 | $1.1K | $1.8K | $2.5K | $1.8K | $8.6K |
| Deferred Revenue (Current) | -- | $0 | $34K | $34K | $44K | $38K | $0 | $8.3K |
| Other Current Liabilities | $555K | $550K | -- | -- | -- | $418K | -- | -- |
| **Total Current Liabilities** | $597K | $578K | $568K | $542K | $527K | $494K | $400K | $375K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $597K | $578K | $568K | $542K | $527K | $494K | $400K | $375K |
| Common Stock | $130K | $130K | $130K | $130K | $130K | $130K | $130K | $130K |
| Retained Earnings | -$14.17M | -$14.15M | -$14.14M | -$14.11M | -$14.10M | -$14.06M | -$13.97M | -$13.94M |
| **Total Stockholders' Equity** | -$596K | -$577K | -$567K | -$541K | -$525K | -$491K | -$398K | -$367K |
| Total Equity | -$596K | -$577K | -$567K | -$541K | -$525K | -$491K | -$398K | -$367K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$86K | -$183K | -$511K | -$117K | -$3.99M | -$151K | -$151K |
| Stock-Based Compensation | -- | $0 | $325K | $0 | -- | -- | -- |
| Change in Receivables | $0 | $3.7K | -$3.7K | $0 | -- | -- | $329 |
| **Operating Cash Flow** | -$134K | -$164K | -$165K | -$93K | -$163K | -$144K | -$37K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -$7.4K | -$19K |
| Common Stock Issued | -- | -- | $0 | $96K | $81K | $148K | -- |
| **Financing Cash Flow** | $133K | $148K | $143K | $133K | $156K | $158K | $54K |
| **Net Change in Cash** | -$1.7K | -$16K | -$21K | $39K | -$7.1K | $7.1K | -$1.8K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$19K | -$10K | -$26K | -$16K | -$34K | -$93K | -$32K | -$46K |
| Change in Receivables | -- | $0 | $0 | $0 | $0 | $1.7K | $6.7K | -$8.3K |
| **Operating Cash Flow** | -$5.1K | -$36K | -$25K | -$39K | -$34K | -$28K | -$31K | -$60K |
| **Financing Cash Flow** | $5.0K | $35K | $25K | $38K | $34K | $30K | $31K | $58K |
| **Net Change in Cash** | -$95 | -$107 | -$90 | -$790 | -$670 | $2.4K | -$95 | -$1.9K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -872.3% | -301.1% | -1248.8% | -- | -- | -- | -- |
| **Net Profit Margin** | -620.3% | -302.4% | -1249.6% | -3787.3% | -- | -- | -- |
| Return on Assets (ROA) | -9978.9% | -7261.6% | -2318.6% | -295.2% | -1935450.0% | -93.7% | -102.9% |
| Current Ratio | 0.00x | 0.01x | 0.07x | 0.25x | 0.00x | 0.03x | 0.00x |
| Quick Ratio | 0.00x | 0.01x | 0.07x | 0.25x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -77.1% | +47.8% | +1229.3% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1014.6% | -872.3% | -889.5% | -736.2% | -1121.7% | -301.1% | -- | -- |
| **Net Profit Margin** | -685.8% | -620.3% | -889.3% | -736.1% | -1121.4% | -302.4% | -243.2% | -256.5% |
| Return on Assets (ROA) | -9281.7% | -9978.9% | -17419.9% | -16500.0% | -11057.8% | -7261.6% | -7581.0% | -1551.9% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.02x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.02x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -100.0% | +112.8% | -92.4% | +546.8% | +1003.2% | -69.3% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
